Revision 4

#8179Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IHC-P, IF-IC

REACTIVITY:

H M R

SENSITIVITY:

Endogenous

MW (kDa):

18

Source/Isotype:

Rabbit IgG

UniProt ID:

#P52926

Entrez-Gene Id:

8091

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunohistochemistry (Paraffin) 1:200 - 1:800
Immunofluorescence (Immunocytochemistry) 1:200 - 1:800

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

For a carrier free (BSA and azide free) version of this product see product #44990.

Specificity / Sensitivity

HMGA2 (D1A7) Rabbit mAb recognizes endogenous levels of total HMGA2 protein.

Species Reactivity:

Human, Mouse, Rat

Species predicted to react based on 100% sequence homology

Monkey

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human HMGA2 protein.

Background

HMGA2 belongs to the family of high mobility group with AT-hook DNA binding domain. HMGA proteins are considered architectural transcription factors; they do not have direct transcriptional activation capacity, but instead regulate gene expression by changing DNA conformation through binding to AT-rich regions in the DNA and/or direct interaction with other transcription factors (1,2). HMGA2 is abundantly and ubiquitously expressed and plays a crucial role during embryonic development (3). HMGA2 promotes stem cell self-renewal and research studies have shown that decreased HMGA2 expression is associated with stem cell aging (2,4-6). Investigators have shown that expression levels of HMGA2 are very low in normal adult tissues, while either overexpression or rearrangement is associated with many types of cancer (7-10).

  1. Cleynen, I. and Van de Ven, W.J. (2008) Int J Oncol 32, 289-305.
  2. Pfannkuche, K. et al. (2009) Stem Cell Rev 5, 224-30.
  3. Monzen, K. et al. (2008) Nat Cell Biol 10, 567-74.
  4. Nishino, J. et al. (2008) Cell 135, 227-39.
  5. Li, O. et al. (2006) Genesis 44, 523-9.
  6. Li, O. et al. (2007) FEBS Lett 581, 3533-7.
  7. Fusco, A. and Fedele, M. (2007) Nat Rev Cancer 7, 899-910.
  8. Rawlinson, N.J. et al. (2008) Cancer Genet Cytogenet 181, 119-24.
  9. Wei, J.J. et al. (2010) Am J Surg Pathol 34, 18-26.
  10. Mahajan, A. et al. (2010) Mod Pathol 23, 673-81.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IHC-P: Immunohistochemistry (Paraffin) IF-IC: Immunofluorescence (Immunocytochemistry)

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

Revision 4
#8179

HMGA2 (D1A7) Rabbit mAb

Western Blotting Image 1: HMGA2 (D1A7) Rabbit mAb Expand Image
Western blot analysis of extracts from various cell lines using HMGA2 (D1A7) Rabbit mAb.
Immunohistochemistry Image 1: HMGA2 (D1A7) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human colon carcinoma using HMGA2 (D1A7) Rabbit mAb.
Immunohistochemistry Image 2: HMGA2 (D1A7) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded cell pellets, HCT 116 (left) or HBP-ALL (right), using HMGA2 (D1A7) Rabbit mAb.
Immunohistochemistry Image 3: HMGA2 (D1A7) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human uterine leiomyoma using HMGA2 (D1A7) Rabbit mAb.
Immunofluorescence Image 1: HMGA2 (D1A7) Rabbit mAb Expand Image
Confocal immunofluorescent analysis of A549 cells, untreated (left) or treated with hTGF-β1 #8915 (10 ng/ml) and hIL-1β #8900 (5 ng/ml, 48 hr; right), using HMGA2 (D1A7) Rabbit mAb (green). Actin filaments were labeled with DY-554 phalloidin (red).